Conceptio
›
Archive
›
NCBI PubMed Central
NCBI PubMed Central
open access
First-in-human (phase I) trial of SOL-116, a humanised IgG4 monoclonal antibody targeting bile salt-stimulated lipase, in healthy participants and rheumatoid arthritis patients.
Meijs AC et al.
NCBI PubMed Central · Papers · License: Open Access
Open Source ↗
Direct PDF ↓
machine learning systems
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record
· ID 308802
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.